Figure][1] Katherine W. Ferrara, PhD Dr. Katherine W. Ferrara is a professor of radiology at Stanford University and the ...
PET/CT offers excellent accuracy in the staging of high-risk prostate cancer (PCa), yet outcomes-based evidence of the clinical benefit remains limited. We aimed to determine whether the rates of ...
Pulmonary hypertension (PH) is a progressive disease with a poor prognosis. Identifying chronic thromboembolic pulmonary disease as a cause of PH has major clinical implications as these patients ...
Journal of Nuclear Medicine April 2026, jnumed.125.271565; DOI: https://doi.org/10.2967/jnumed.125.271565 ...
Journal of Nuclear Medicine April 2026, jnumed.125.271421; DOI: https://doi.org/10.2967/jnumed.125.271421 ...
Objectives Radiolabeled DOTA-peptides are applied in Peptide Receptor Radionuclide Therapy (PRRT). For PRRT of receptor-mediated processes the (pre)clinically applied amount of DOTA-peptides is in the ...
One of the early promises of PET was that it would be quantitative (1), as opposed to imaging modalities such as x-ray CT, MRI, or SPECT, in which quantification is more of a challenge than in PET. By ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results